Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes
Phase 2
Completed
- Conditions
- Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
- Interventions
- Other: PlaceboDrug: Biphasic Remogliflozin Etabonate
- First Posted Date
- 2015-09-01
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- BHV Pharma
- Target Recruit Count
- 191
- Registration Number
- NCT02537470
- Locations
- 🇺🇸
Advanced Arizona Clinical Research, Tucson, Arizona, United States
🇺🇸Long Beach Clinical Trials, Long Beach, California, United States
🇺🇸Long Beach Center for Clinical Research, Long Beach, California, United States
News
No news found